BioWorld Asia

Oct. 20, 2004

Arpida Acquires Combio Through All-Share Deal, Brings In CHF33M

Arpida Ltd. acquired its erstwhile partner Combio A/S in an all-stock transaction that will boost its chemistry capabilities and expand its head count from 47 to 73 employees. (BioWorld International) Read More

Insurance Costs Prompt Mass Exodus From LION Bioscience

HIV Receptor Blocker Holds Hope For Vaginal Microbicide

Allergan Returns Rights To PEP005; Peplin's Stock Falls

TxCell Closes EUR10.5M Series A Financing For Trl Cell Therapies

Preclinical Alzheimer's Data Trigger Change At Sirenade

Respiratory Disease Company Synairgen Seeking EUR10M IPO

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 3, 2026

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...